RNGE Stock Overview
Range Impact, Inc., together with its subsidiaries, provides health and wellness products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Range Impact, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.38 |
| 52 Week High | US$0.55 |
| 52 Week Low | US$0.10 |
| Beta | 2.45 |
| 1 Month Change | 5.56% |
| 3 Month Change | 17.14% |
| 1 Year Change | 122.22% |
| 3 Year Change | 118.14% |
| 5 Year Change | -5.00% |
| Change since IPO | -94.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNGE | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | 11.4% | 2.4% | 1.0% |
| 1Y | 122.2% | 30.7% | 21.9% |
Return vs Industry: RNGE exceeded the US Commercial Services industry which returned 31.1% over the past year.
Return vs Market: RNGE exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| RNGE volatility | |
|---|---|
| RNGE Average Weekly Movement | 16.1% |
| Commercial Services Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RNGE has not had significant price volatility in the past 3 months.
Volatility Over Time: RNGE's weekly volatility has decreased from 25% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 56 | Mike Cavanaugh | www.rangeimpact.com |
Range Impact, Inc., together with its subsidiaries, provides health and wellness products in the United States. The company operates through five segments: Range Reclaim, Range Water, Range Security, Range Land, and Drug Development. It develops VBX-100, a glycosylated tetrahydrocannabinol cannabinoid for the inflammatory conditions of the gastrointestinal tract.
Range Impact, Inc. Fundamentals Summary
| RNGE fundamental statistics | |
|---|---|
| Market cap | US$38.39m |
| Earnings (TTM) | US$3.13m |
| Revenue (TTM) | US$19.35m |
12.3x
P/E Ratio2.0x
P/S RatioIs RNGE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNGE income statement (TTM) | |
|---|---|
| Revenue | US$19.35m |
| Cost of Revenue | US$13.11m |
| Gross Profit | US$6.23m |
| Other Expenses | US$3.10m |
| Earnings | US$3.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.031 |
| Gross Margin | 32.23% |
| Net Profit Margin | 16.18% |
| Debt/Equity Ratio | 108.8% |
How did RNGE perform over the long term?
See historical performance and comparison